• MetLife (NYSE:MET) announces a new US$3b share repurchase authorization approved by its board.
• The buyback plan reflects board confidence in MetLife's long term outlook and financial strength.
• The authorization adds new capacity for returning capital to shareholders through stock repurchases.

Consider looking at other insurers and financial stocks that may also be using buybacks or dividends to return capital to shareholders through 51 high quality undervalued stocks

MetLife sits among the largest global insurers, so investors often watch its stock as a proxy for sentiment toward the broader insurance sector. The shares trade at US$96.26 and have delivered gains of 19.8% year to date and 30.4% over the past year, with returns of 68.0% over three years and 78.7% over five years, which many readers may view as a meaningful track record.

How does this new buyback fit with MetLife’s dividend story?

The new US$3b repurchase authorization sits alongside a dividend profile that already looks important for MetLife. The company recently declared a second quarter 2026 dividend of US$0.5925 per share, described as a 4.4% increase from the first quarter dividend of US$0.5675. Analysts also describe the dividend as reliable with a yield of 2.36%. Together, regular increases and ongoing buybacks indicate that management sees current cash flows as supportive of returning capital through both channels rather than choosing only one.

What does this signal about payout sustainability and MetLife’s cash flows?

For MetLife, a higher dividend per share, continued buybacks, and expectations for earnings growth of 13.74% per year point to a board that is comfortable committing more of the cash flow stream to shareholders. The company is also described as having a high level of debt, so the balance between servicing that debt, funding growth initiatives and maintaining the dividend will be important. The mix of an increased quarterly dividend and a fresh US$3b authorization suggests the board currently views the payout ratio as manageable within that broader capital structure.

What should investors watch next for this MetLife buyback to really matter?

The key test will be how MetLife executes against this authorization over the next 12 to 18 months. Investors can watch the quarterly share count, the pace of repurchases relative to the US$3b capacity, and future dividend decisions after the June 9, 2026 payment date. If earnings progress in line with current forecasts while the company steadily retires stock and maintains its dividend growth pattern, the combined impact on per share metrics and total capital returned will become much clearer.

For the full picture including more risks and rewards, check out the complete MetLife analysis. Alternatively, you can check out the community page for MetLife to see how other investors believe this latest news will impact the company's narrative.

Stay updated on the most important news stories for MetLife by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on MetLife.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.